Robert Millman, formerly the chief IP counsel for Alnylam Pharmaceuticals, has joined healthcare venture capital firm MPM Capital as an executive partner.
Before Alnylam, Millman served as patent counsel at Millennium Pharmaceuticals.
Nastech Pharmaceutical has appointed Gunter Blobel to the scientific advisory board of its RNAi drugs subsidiary MDRNA.
Blobel is an investigator at Rockefeller University and the 1999 recipient of the Nobel Prize in physiology or medicine.